Ischemia-modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease

Altunoglu E., GUNTAS G., Erdenen F., AKKAYA E., TOPAC I., Irmak H., ...Daha Fazla

GERIATRICS & GERONTOLOGY INTERNATIONAL, cilt.15, sa.7, ss.872-880, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 15 Konu: 7
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1111/ggi.12361
  • Sayfa Sayıları: ss.872-880


BackgroundThe aim of the present study was to determine the systemic levels of oxidative stress markers, such as ischemia-modified albumin (IMA), advanced oxidation protein products (AOPP), ferric reducing antioxidant power (FRAP) and the prooxidant-antioxidant balance (PAB), to clarify protein redox homeostasis in patients with Alzheimer's disease, and to compare them with mentally healthy persons of the same age.